who invented glp 1 drugs Reflections on the discovery GLP-1 as a satiety hormone: Implications for obesity therapy and future directions GLP-1 | Summary
Description
The STEP 8 trial demonstrated similar rates of adverse events for semaglutide and liraglutide, but with less discontinuation due to adverse events with semaglutide [33]

This, however, does not apply to other GLP-1RAs approved for the treatment of T2DM, including the same liraglutide (Victoza) and semaglutide (Ozempic or Rybelsus) at lower dosages, prompting several stakeholders to request an updated guidance 232 and more caution in media enthusiasm 233

Ann Gen Psychiatry

The fix: begin a resistance training program as soon as possible after starting GLP-1 therapy

Henry Sobo

Check-in on your weight, emotional and physical changes with an easy text or call
